Synchron is the undisputed leader in the minimally invasive BCI space.
Under the radar for now - more info soon.
2025
XEIA invests
2025
Synchron raises $200M Series D led by Double Point Ventures, alongside ARCH, Khosla and Bezos Expeditions
Synchron raises $200M Series D led by Double Point Ventures, alongside ARCH, Khosla and Bezos Expeditions
The latest from
Synchron*
Stay up to date on Human 3 - the new epoch of health, wellbeing and performance